Trade

with

Affymetrix Inc
(NASDAQ: AFFX)
AdChoices
7.86
+0.21
+2.75%
After Hours :
7.86
+0.00
+0.01%

Open

7.88

Previous Close

7.65

Volume (Avg)

409.39k (509.22k)

Day's Range

7.68-7.89

52Wk Range

6.25-9.80

Market Cap.

576.78M

Dividend Rate ( Yield )

-

Beta

0.79

Shares Outstanding

73.38M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
  • Management effectiveness
Industry Diagnostics & Research
Highlights
Analyst Recommendation: Not Available
    • Revenue

    • 330.40M

    • Net Income

    • -16.33M

    • Market Cap.

    • 576.78M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -1.81

    • PEG (Price/Earnings Growth) Ratio

    • 1.14

    • Beta

    • 0.79

    • Forward P/E

    • 37.45

    • Price/Sales

    • 1.62

    • Price/Book Value

    • 2.09

    • Price/Cash flow

    • 14.04

      • EBITDA

      • 36.53M

      • Return on Capital %

      • -1.25

      • Return on Equity %

      • -2.34

      • Return on Assets %

      • -1.25

      • Book Value/Share

      • 3.66

      • Shares Outstanding

      • 73.38M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      -
      Not Available
        • 1 Year Price Target

        • 9.00

        • Credit Rating

        • -

        • Analysts

        • 0

        • EPS Estimate

        • 0.09

        • Cashflow Estimate

        • 0.52

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 7.50

          • 21.91

          • Net Income

            YTD/YTD (last year)

          • -

          • -5.55

          • Net Income

            Q/Q (last year)

          • -

          • 0.44

          • Sales (Revenue)

            5-Year Annual Average

          • -4.24

          • 47.82

          • Net Income

            5-Year Annual Average

          • -

          • 4.98

          • Dividends

            5-Year Annual Average

          • -

          • 5.31

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 56.90

            • 42.70

            • Pre-Tax Margin

            • -1.62

            • 11.63

            • Net Profit Margin

            • -1.81

            • 9.55

            • Average Gross Margin

              5-Year Annual Average

            • 56.00

            • 43.76

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -8.10

            • 11.34

            • Average Net Profit Margin

              5-Year Annual Average

            • -5.90

            • 52.13B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 0.47

              • 0.62

              • Current Ratio

              • 2.74

              • 1.23

              • Quick Ratio

              • 1.70

              • 0.76

              • Interest Coverage

              • 0.47

              • 5.98

              • Leverage Ratio

              • 1.78

              • 2.16

              • Book Value/Share

              • 3.66

              • 14.94

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -90.09

                • 32.79

                • P/E Ratio 5-Year High

                • -114.83

                • 325.07

                • P/E Ratio 5-Year Low

                • -34.68

                • 154.73

                • Price/Sales Ratio

                • 1.63

                • 2.30

                • Price/Book Value

                • 2.10

                • 2.98

                • Price/Cash Flow Ratio

                • 14.04

                • 18.76

                • Key Metrics

                • Company

                  • Shares Short

                    as of -

                  • -

                  • Short Ratio

                    as of -

                  • -

                  • Short % of Float

                    as of -

                  • -

                  • Shares Short

                    prior month

                  • -

                  • Trailing Annual Dividend Yield

                  • -

                  • 5 Year Average Dividend Yield

                  • -

                  • Key Metrics

                  • Company

                    • Payout Ratio

                    • -

                    • Dividend Date

                    • -

                    • Ex-Dividend Date

                    • -

                    • Last Split Factor

                      new per old

                    • -

                    • Last Split Date

                    • -

                    • Key Metrics

                    • Company

                    • Industry

                      • Return on Equity %

                        (5-Year Average)

                      • -2.34

                        (-6.20)

                      • 9.34

                        (9.80)

                      • Return on Assets %

                        (5-Year Average)

                      • -1.25

                        (-3.40)

                      • 4.63

                        (5.44)

                      • Return on Capital %

                        (5-Year Average)

                      • 0.75

                        (-5.60)

                      • 5.73

                        (6.77)

                      • Income/Employee

                      • -

                      • 17.17k

                      • Inventory Turnover

                      • 2.39

                      • 5.07

                      • Asset Turnover

                      • 0.69

                      • 0.48

                      Current Historical
                      Financials
                      • Income Statement
                      • Balance Sheet
                      • Cash Flow
                      Operating Income
                      -12.55M
                      Operating Margin
                      -3.80
                      Total Equity
                      -
                      Retained Earnings
                      -
                      Free Cashflow
                      -
                      Price/Cashflow
                      14.04
                      Ownership

                      Institutional Ownership

                      -

                      Top 10 Institutions

                      63.05%

                      Mutual Fund Ownership

                      53.00%

                      Float

                      71.24%

                      5% / Insider Ownership

                      2.81%

                      Corporate insiders or major stockholders reporting trading activity in the stock.

                      Top Mutual Fund Owners

                      Top Institutional Owners

                      Mutual Fund Name

                      Institution Name

                      • Mutual Fund Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • PrimeCap Odyssey Aggressive Growth Fund

                      •  

                        4,850,000

                      • 0.00

                      • 6.67

                      • Undrly Pru (M&G) Am Bd Life

                      •  

                        3,040,878

                      • 0.00

                      • 4.23

                      • Vanguard Capital Opportunity Fund

                      •  

                        2,700,600

                      • 0.00

                      • 3.71

                      • Transamerica Large Cap Value

                      •  

                        1,813,792

                      • 1.24

                      • 2.49

                      • Biotech Growth Trust Plc

                      •  

                        1,572,000

                      • 0.00

                      • 2.16

                      • iShares Core S&P Small-Cap (AU)

                      •  

                        1,479,054

                      • 0.24

                      • 1.94

                      • Vanguard Total Stock Mkt Idx

                      •  

                        1,172,959

                      • 0.51

                      • 1.60

                      • iShares Russell 2000 (AU)

                      •  

                        1,117,818

                      • -0.89

                      • 1.47

                      • FPIL M&G Global Leaders USD

                      •  

                        1,088,690

                      • 2.07

                      • 1.51

                      • iShares Nasdaq Biotechnology

                      •  

                        956,141

                      • -1.85

                      • 1.25

                      • Institution Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • PRIMECAP Management Company

                      •  

                        10,559,240

                      • -1.23%

                      • 14.51

                      • Orbimed Advisors, LLC

                      •  

                        6,568,000

                      • -1.87%

                      • 9.03

                      • Levin Capital Strategies, L.P.

                      •  

                        5,443,623

                      • +2.10%

                      • 7.48

                      • M&G INVESTMENT MANAGEMENT LTD

                      •  

                        5,156,928

                      • +131.60%

                      • 7.09

                      • BlackRock Fund Advisors

                      •  

                        4,771,832

                      • -4.75%

                      • 6.56

                      • Dimensional Fund Advisors, Inc.

                      •  

                        3,893,284

                      • -10.32%

                      • 5.35

                      • Vanguard Group, Inc.

                      •  

                        3,312,565

                      • +9.67%

                      • 4.55

                      • Acadian Asset Management LLC

                      •  

                        2,602,669

                      • +53.00%

                      • 3.55

                      • Russell Frank Co

                      •  

                        2,012,301

                      • +7.80%

                      • 2.77

                      • Neuberger Berman LLC

                      •  

                        1,573,020

                      • -10.37%

                      • 2.16

                      Company Profile

                      Sector

                      Healthcare

                      Industry

                      Diagnostics & Research

                      Type

                      Slow Growth

                      Style

                      Small Growth

                      Affymetrix Inc was incorporated in California in 1992 and reincorporated in Delaware in 1998. The Company is a provider of life science tools and molecular diagnostic products that enable parallel analysis of biological systems at th...moree gene, protein and cell level. It sells its products to genomic research centers, academic institutions, government and private laboratories, as well as pharmaceutical, diagnostic and biotechnology companies. The Companys operations consist of two reportable segments, Affymetrix Core and eBioscience. Affymetrix Core is divided into three business units with each business unit having its own research, development and marketing groups to better serve customers and respond quickly to the market needs. The three business units that form Affymetrix Core are; Expression, Gene...moretic Analysis and Clinical Applications, and Life Science Reagents. Expression: This business unit develops and markets the Company's GeneChip gene expression products and services, and the QuantiGene line of low-to-mid-plex RNA measurement products; Genetic Analysis and Clinical Applications. This business unit develops and markets the Company's genotyping, such as the Axiom product line and clinical research applications, such as the CytoScan cytogenetics; Life Science Reagents; This business unit develops and sells reagents, enzymes, purification kits and biochemicals used by life science researchers. eBioscience; This reportable segment specializes in the development, manufacturing, marketing and distribution of research tools in the areas of flow cytometry, immunoassays, microscopic imaging and other protein-based analyses. The Company markets and distributes its products directly to customers in North America, Japan and major European markets. The Company is facing competition as existing companies develop new or improved products, and as companies enter the market with new technologies, such as next-generation sequencing. In the highly multiplexed genotyping and gene expression markets, existing competitive technologies include DNA sequencing, which the Company does not offer and is offered by companies such as Illumina, Inc., Life Technologies Corporation and Pacific Biosciences of California, Inc. The Companys operations are subject to complex and stringent environmental, health, safety and other governmental laws and regulations.lessless

                      Key People

                      Dr. Frank R. Witney,,PhD

                      CEO/Director/President

                      Dr. Stephen P.A. Fodor,PhD

                      Founder/Chairman of the Board/Director

                      Gavin Wood

                      CFO/Chief Accounting Officer/Executive VP

                      Dr. Gary S. Guthart,PhD

                      Director

                      Jami K. Dover Nachtsheim

                      Director

                      • Affymetrix Inc

                      • 3420 Central Expressway

                      • Santa Clara, CA 95051

                      • USA.Map

                      • Phone: +1 408 731-5000

                      • Fax: +1 408 731-5380

                      • affymetrix.com

                      Incorporated

                      1992

                      Employees

                      1,100

                      Send Feedback

                      We appreciate your input!

                      • I'm having trouble signing into my Microsoft account

                      • I’m having problems with the services stripe (Mail, Facebook, etc.)

                      • There is an issue with my weather information

                      • I see an error in the content

                      • Other

                      Please give an overall site rating: